During the last session, Pfizer Inc. (NYSE:PFE)’s traded shares were 29.2 million, with the beta value of the company hitting 0.63. At the end of the trading day, the stock’s price was $37.83, reflecting an intraday loss of -2.07% or -$0.8. The 52-week high for the PFE share is $54.93, that puts it down -45.2 from that peak though still a striking 4.39% gain since the share price plummeted to a 52-week low of $36.17. The company’s market capitalization is $211.88B, and the average intraday trading volume over the past 10 days was 37.33 million shares, and the average trade volume was 24.29 million shares over the past three months.
Pfizer Inc. (PFE) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.50. PFE has a Sell rating from 0 analyst(s) out of 25 analysts who have looked at this stock. 14 analyst(s) recommend to Hold the stock while 2 suggest Overweight, and 9 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.61.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Pfizer Inc. (NYSE:PFE) trade information
Pfizer Inc. (PFE) registered a -2.07% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -2.07% in intraday trading to $37.83 this Thursday, 05/25/23, hitting a weekly high. The stock’s 5-day price performance is 3.70%, and it has moved by -2.07% in 30 days. Based on these gigs, the overall price performance for the year is -29.17%. The short interest in Pfizer Inc. (NYSE:PFE) is 43.87 million shares and it means that shorts have 2.23 day(s) to cover.
The consensus price target of analysts on Wall Street is $46.42, which implies an increase of 18.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $35.00 and $75.00 respectively. As a result, PFE is trading at a discount of -98.26% off the target high and 7.48% off the low.
Pfizer Inc. (PFE) estimates and forecasts
Statistics show that Pfizer Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Pfizer Inc. (PFE) shares have gone down -22.92% during the last six months, with a year-to-date growth rate less than the industry average at -49.09% against -5.90. Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to shrink -70.10% this quarter and then drop -59.60% in the quarter after that. In the rating firms’ projections, revenue will decrease -32.60% compared to the previous financial year.
Revenue for the current quarter is expected to be $13.86 billion as predicted by 14 analyst(s). Meanwhile, a consensus of 13 analyst(s) estimates revenue growth to $15.75 billion by the end of Sep 2023. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $27.74 billion and $21.04 billion respectively. In this case, analysts expect current quarter sales to shrink by -50.00% and then drop by -25.10% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 22.70%. While earnings are projected to return 39.30% in 2023, the next five years will return -14.94% per annum.
Pfizer Inc. is due to release its next quarterly earnings between July 26 and July 31. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Pfizer Inc. is 1.64, with the dividend yield indicating at 4.34 percent, continuing the trend of increasing dividends in recent years.
Pfizer Inc. (NYSE:PFE)’s Major holders
Pfizer Inc. insiders own 0.03% of total outstanding shares while institutional holders control 70.67%, with the float percentage being 70.70%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 3,999 institutions own stock in it. As of Mar 30, 2023, the company held over 508.39 million shares (or 9.01% of all shares), a total value of $20.74 billion in shares.
The next largest institutional holding, with 445.38 million shares, is of Blackrock Inc.’s that is approximately 7.89% of outstanding shares. At the market price on Mar 30, 2023, these shares were valued at $18.17 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Pfizer Inc. (PFE) shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. Data provided on Dec 30, 2022 indicates that Vanguard Total Stock Market Index Fund owns about 170.64 million shares. This amounts to just over 3.02 percent of the company’s overall shares, with a $8.74 billion market value. The same data shows that the other fund manager holds slightly less at 129.76 million, or about 2.30% of the stock, which is worth about $6.65 billion.